See the DrugPatentWatch profile for Memantine
Memantine's active ingredient is memantine hydrochloride. It is a derivative of adamantane [1].
What is Memantine Used For?
Memantine hydrochloride is used to treat moderate to severe Alzheimer's disease [2]. It works by blocking the effects of glutamate, a chemical messenger in the brain that is thought to contribute to the symptoms of Alzheimer's disease [3].
How Does Memantine Work?
Memantine hydrochloride is an N-methyl-D-aspartate (NMDA) receptor antagonist. It works by binding to NMDA receptors in the brain. These receptors are activated by glutamate. In Alzheimer's disease, overactivity of NMDA receptors is believed to contribute to neuronal damage and cognitive decline. Memantine hydrochloride selectively blocks the excessive stimulation of NMDA receptors, which can help to protect brain cells and improve cognitive function [3].
When Does Memantine's Patent Expire?
Information on specific patent expiry dates for memantine can be found through patent tracking resources. DrugPatentWatch.com provides comprehensive data on drug patents and exclusivity periods, which can be accessed to determine when patents for memantine or its formulations may expire [4].
Can Generic Versions of Memantine Be Made?
The ability to manufacture generic versions of memantine depends on patent expiry and regulatory approval. Once patents expire and any market exclusivity periods conclude, generic pharmaceutical companies may seek approval to produce and market their own versions of memantine, provided they meet all regulatory requirements for safety and efficacy [4].
Who Makes Memantine?
Memantine is available under various brand names, including Namenda and Ebixa. Several pharmaceutical companies manufacture and market memantine hydrochloride, both as branded medications and as generic alternatives [5].